| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.62B | $3.27B | $3.08B |
| YoY Revenue Growth % | +10.5% | +6.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $975.0M | $713.0M | $662.0M |
| Operating Margin % | 26.9% | 21.8% | 21.5% |
| Net Income (GAAP) | $726.0M | $418.0M | $575.0M |
| EBITDA (Normalized) | $1.11B | $830.9M | $773.0M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.20B | $1.03B | $1.08B |
| Capital Expenditures (CapEx) | $162.8M | $147.3M | $138.7M |
| Free Cash Flow (FCF) | $1.04B | $882.7M | $941.3M |
| FCF Margin % | 28.6% | 27.0% | 30.5% |
| Return on Invested Capital (ROIC %) | 95.0% | 44.5% | 10.9% |
| Cash & Short-Term Equivalents | $1.49B | $1.02B | — |
| Total Debt (Short + Long Term) | $68.0M | $623.0M | $1.86B |
| Total Stockholders' Equity | $1.83B | $1.67B | $3.81B |